Diagnosis and Treatment of Cardiovascular Conditions in Medicare Advantage In-Home Health Risk Assessments
Authors' conclusion
Among Medicare Advantage beneficiaries, an increasingly large share of cardiovascular conditions are being diagnosed through in-home HRAs, but treatment rates after these diagnoses are consistently lower than after facility-based encounters.
Study context
- Population
- Medicare Advantage beneficiaries diagnosed with a cardiovascular risk factor or diseaseMedicare Advantage beneficiaries diagnosed with a cardiovascular risk factor or disease
- Participants
- 21,496,506 beneficiaries
- Exposure
- in-home health risk assessments (HRAs) vs facility-based visits
Methodological detailspopulation-based
- Population-based
Main finding
As reported in the abstract
Proportion of cardiovascular conditions diagnosed during in-home HRAs · 2018 to 2022
- Hypertension
- 45.9% to 47.7%
- Hyperlipidemia
- 57.8% to 66.7%
- Diabetes
- 47.8% to 51.6%
- Atrial fibrillation
- 30.0% to 36.0%
- Ischemic heart disease
- 37.2% to 41.6%
- Peripheral vascular disease
- 64.5% to 73.9%
- Heart failure
- 34.7% to 42.6%
Observational data: associations, not effects.
Further findings
Characteristics associated with HRA-based diagnoses
- Racial and ethnic minority beneficiaries and those enrolled in lower-rated plans were more likely to receive HRA-based diagnoses
Treatment rates after diagnosis
- Treatment rates were substantially lower after HRA-based diagnoses across all conditions
- Prescription fills were used as a proxy for management
Original publication
Diagnosis and Treatment of Cardiovascular Conditions in Medicare Advantage In-Home Health Risk Assessments. Ann Intern Med. Published 20 October 2026. doi:10.
Summarised from the published abstract; every number is checked against it